License Fees for a Compulsory License – Isentress II – German Federal Patent Court
09/05/2018 | Dr. Raphael Bösl
As a follow-up to our posts of July 12, 2017 and August 31, 2017. Below please find an English translation of the Guiding Principles of a decision of the German Federal Patent Court concerning the assessment of license fees for a compulsory license for a medicament against AIDS (Isentress/Raltegravir). Also posted is the entire decision in German for your convenience. Our Munich partner, Fritz Lahrtz, was one of the leading attorneys in this case.